Drug level of resistance of emerging SARS-CoV-2 variations is also a problem as exemplified from the action from the FDA in January 2022 to limit the usage of the anti-S mAb cocktail of bamlanivimab and etesevimab, aswell while the mAb cocktail of imdevimab and casirivimab in COVID-19 individuals, as both these mAb cocktails aren’t dynamic against the Omicron version, that was circulating in america at an extremely high frequency at that best period [31]

Drug level of resistance of emerging SARS-CoV-2 variations is also a problem as exemplified from the action from the FDA…

Continue Reading →

The next primary antibodies were used: rabbit anti-horseradish peroxidase (HRP) (1:500), mouse anti-Elav (1:10), mouse anti-BP104 (1:10), mouse anti-Prospero (1:10), mouse anti-cyclin A (through the Developmental Research Hybridoma Standard bank, Iowa city, Iowa), mouse anti-Worniu (1:1000) kindly supplied by Dr

The next primary antibodies were used: rabbit anti-horseradish peroxidase (HRP) (1:500), mouse anti-Elav (1:10), mouse anti-BP104 (1:10), mouse anti-Prospero (1:10),…

Continue Reading →